2Kornbluth A, Present DH, Lichtiger S, et al. Cyclosporine for severe ulcerative colitis: A user's guide. Am J Gastroentero], 1997,92(9):1424-1428.
3Chey WY, Hussain A, Ryan C, et al.Infliximab for refractory ulcerative colitis. Am J Gastroenterol, 2001,96(8) : 2373 - 2381.
4Steinhart AH, Hemphill D, Greenberg GR. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: A meta-analysis. Am J Gastroenterol, 1994,89(12):2116 - 2124.
5Korelitz BI, Present DH. Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease. Dig Dis Sci, 1985,30(1):58-64.
6Present DH, Lichtiger S, Efficacy of cyclosporine in treatment of fistulaeof Crohn's disease. Dig Dis Sci, 1994,39(2):374 - 380.
7Bouhnik Y, Lemann M, Mary JY, et al. Long term follow-up of patients with Crohn ' s disease treated with azathioprine or 6-mejrcaptopurine.Lancet, 1996,347(8996):215 - 219.
8Rutgeerts P, Hiele M, Gebces K, et al. Controlled trial of metronidazole treatment for prevention of Crohn' s recurrence after ileal resection. Gastroenterology, 1995,108(6):1617 - 1621.
9Caprilli R, Andreoli A, Capursi L, et al. Oral mesalamine (Asacol) for prevention of postoperative recurrence of Crohn' s desease. Aliment Pharmacol Ther, 1994,8(1) :35 - 43.
10Achkar JP, Hanauer SB. Medical therapy to reduce postoperative Crohn's disease recurrence. Am J Gastroenterol, 2000,95 (5) : 1139 - 1146.
